Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 4 Open-market sale Director sold 50,000 shares at $4.31 ($215,500)
  2. 4 Open-market sale VP, Tech Management sold 48,000 shares at $4.74 ($227,520)
  3. 4 Open-market sale Director sold 300,000 shares at an average $4.75 ($1,426,170)
  4. 4 Open-market sale CEO and Director sold 110,650 shares at an average $4.82 ($533,360)
  5. 4 Open-market sale VP, Tech Management sold 74,100 shares at $4.78 ($354,198)
  6. 4 Open-market sale COO and CFO sold 42,844 shares at $5.01 ($214,648)
  7. 4 Open-market sale Director sold 80,000 shares at $4.92 ($393,600)
  8. 4 Exercise or conversion CEO and Director acquired 60,750 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 77,500 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 257,500 shares (option exercise)
  11. 4/A Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 24 · 475 filings